FOX04-DRI 10mg (Proxofim) For Sale

Research Studies:

• Facilitates analysis of FOXO4-p53 interaction inhibition for investigating targeted senolysis
• Supports investigation into p53-mediated mitochondrial apoptosis in senescent cell assays
• Enables research on selective elimination of senescent fibroblasts and myofibroblasts
• Useful for evaluating homeostatic recovery and cellular rejuvenation in aging-related models

 

Description

FOXO4-DRI 10mg (Proxofim) is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

• Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
• Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
• Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
• Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

• Supports compound characterization in controlled laboratory settings.
• Provides batch-specific identity and purity documentation for research review.
• Allows lot-level traceability across laboratory documentation workflows.
• Supports comparison of product labeling, analytical documentation, and storage information during research planning.
• Supports analytical review of peptide research materials within a strictly laboratory-focused context.

Specifications and Documentation

• Certificate of Analysis: Available with batch-specific documentation where applicable.
• Material Safety Data Sheet: Coming Soon.
• Handling and Storage Instructions: Coming Soon.
• Product Form: Lyophilized powder.
• Purity Specification: ≥99% purity.
• Intended Use: Laboratory research use only.

FOXO4-DRI 10mg (Proxofim) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information

CAS No.	2460055-10-9
Purity	≥99%
Sequence	D-(Leu-Thr-Leu-Arg-Lys-Glu-Pro-Ala-Ser-Glu-Ile-Ala-Gln-Ser-Ile-Leu-Glu-Ala-Tyr-Ser-Gln-Asn-Gly-Trp-Ala-Asn-Arg-Arg-Ser-Gly-Gly-Lys-Arg-Pro-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly)
Molecular Formula	C₂₂₈H₃₈₈N₈₆O₆₄
Molecular Weight	358.06 g/mol
Applications	Senescence research, anti-aging studies, degenerative disease models
Synthesis	Solid-phase synthesis
Solubility	Soluble in water or 1% acetic acid
Stability & Storage	Stable for up to 24 months at -20°C.
Appearance	White lyophilized powder
Shipping Conditions	Shipped at ambient temperature; once received, store at -20°C
Regulatory/Compliance	Manufactured in a facility that adheres to cGMP guidelines
Safety Information	Refer to provided MSDS

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition.